Variant report
Variant | nsv519593 |
---|---|
Chromosome Location | chr9:15855317-15861885 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs1578558 | chr9:15855317-15855318 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs60303840 | chr9:15855326-15855327 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs113826873 | chr9:15855337-15855338 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs544871384 | chr9:15855358-15855359 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs57149079 | chr9:15855425-15855426 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs546585127 | chr9:15855438-15855439 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs566399335 | chr9:15855446-15855447 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs11515071 | chr9:15855545-15855546 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs181497006 | chr9:15855552-15855553 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs143902668 | chr9:15855607-15855608 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs541571816 | chr9:15855725-15855726 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs114385992 | chr9:15855739-15855740 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs558343890 | chr9:15855759-15855760 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs530430808 | chr9:15855782-15855783 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs545734733 | chr9:15855784-15855785 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs571789746 | chr9:15855819-15855820 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs564247118 | chr9:15855837-15855838 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs528362415 | chr9:15855847-15855848 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs184085118 | chr9:15855875-15855876 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs73422709 | chr9:15855877-15855878 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs529097864 | chr9:15855879-15855880 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs188620048 | chr9:15855887-15855888 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs539879522 | chr9:15855907-15855908 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs539454109 | chr9:15855927-15855928 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs558096520 | chr9:15855930-15855931 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs181067826 | chr9:15855953-15855954 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs144271875 | chr9:15855973-15855974 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs555637371 | chr9:15855976-15855977 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs573934976 | chr9:15855992-15855993 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs7873012 | chr9:15856046-15856047 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs116023693 | chr9:15856073-15856074 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs575269127 | chr9:15856206-15856207 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs545498296 | chr9:15856216-15856217 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs564144617 | chr9:15856254-15856255 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs557206585 | chr9:15856256-15856257 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs528074323 | chr9:15856275-15856276 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs543865224 | chr9:15856285-15856286 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs540582837 | chr9:15856289-15856290 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs561954408 | chr9:15856316-15856317 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs529111283 | chr9:15856338-15856339 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs562085375 | chr9:15856347-15856348 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs562865322 | chr9:15856354-15856355 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs533500741 | chr9:15856392-15856393 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs77590326 | chr9:15856429-15856430 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs115622197 | chr9:15856461-15856462 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs148668815 | chr9:15856481-15856482 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs549273104 | chr9:15856500-15856501 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs73422714 | chr9:15856501-15856502 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs538068383 | chr9:15856507-15856508 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs186113898 | chr9:15856543-15856544 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
abnormal development | 18461090 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Breast cancer | 21364760 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Developmental delay | 21147756 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Melanoma | 22183965 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Breast cancer | 21611746 | CNVD |
Glycine encephalopathy | 21572526 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Ovarian cancer | 19835627 | CNVD |
Breast cancer | 22522925 | CNVD |
Autism | 20858261 | CNVD |
Epilepsy | 20858261 | CNVD |
Mental retardation | 20858261 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:15830200-15857200 | Weak transcription | Primary hematopoietic stem cells | blood |
2 | chr9:15845000-15858800 | Weak transcription | Thymus | Thymus |
3 | chr9:15847200-15857600 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
4 | chr9:15849000-15873800 | Weak transcription | Fetal Lung | lung |
5 | chr9:15852800-15857400 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
6 | chr9:15854000-15855600 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
7 | chr9:15855600-15856200 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
8 | chr9:15856000-15857200 | Enhancers | Osteobl | bone |
9 | chr9:15856200-15856400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
10 | chr9:15856200-15857000 | Enhancers | HSMM | muscle |
11 | chr9:15856200-15857200 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
12 | chr9:15856400-15857000 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
13 | chr9:15856400-15857400 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
14 | chr9:15857200-15857800 | ZNF genes & repeats | Primary hematopoietic stem cells | blood |
15 | chr9:15857400-15858000 | ZNF genes & repeats | Foreskin Melanocyte Primary Cells skin03 | Skin |
16 | chr9:15857400-15858200 | ZNF genes & repeats | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
17 | chr9:15857600-15857800 | ZNF genes & repeats | Breast Myoepithelial Primary Cells | Breast |
18 | chr9:15857800-15885400 | Weak transcription | Primary hematopoietic stem cells | blood |
19 | chr9:15858000-15859600 | Strong transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
20 | chr9:15858200-15862600 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
21 | chr9:15859200-15860400 | Enhancers | HUVEC | blood vessel |
22 | chr9:15859600-15861200 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
23 | chr9:15861200-15861400 | ZNF genes & repeats | Foreskin Melanocyte Primary Cells skin03 | Skin |